A Prospective, Randomized Study of Fixed Versus Variable Dosing of 4-factor Prothrombin Complex Concentrate for Emergent Warfarin Reversal at a Large Tertiary Care Medical Center
Phase of Trial: Phase IV
Latest Information Update: 09 Jun 2018
At a glance
- Drugs Prothrombin complex concentrate (Primary)
- Indications Haemorrhage
- Focus Therapeutic Use
- 09 Apr 2018 Planned End Date changed from 15 Mar 2020 to 1 Jan 2019.
- 09 Apr 2018 Planned primary completion date changed from 15 Mar 2020 to 31 Dec 2018.
- 11 Apr 2017 Status changed from not yet recruiting to recruiting.